💨 Abstract
The author, diagnosed with secondary breast cancer in 2022, expresses frustration over the NHS's rejection of a potentially life-extending drug, Enhertu. Initially diagnosed with primary breast cancer in 2020, she faced delays and errors in treatment due to COVID-19. Despite her advocacy and the drug's approval in Scotland and other European countries, she and others in England, Wales, and Northern Ireland are denied access.
Courtesy: Sophie Blake
Suggested
I’m sick of Santa getting credit – I told my youngest the truth
‘Emotional administration’ was costing me £500 at Christmas
‘I wrapped Christmas in smiles while hiding a devastating truth’
We listened to ‘bad’ Christmas songs to see if they’re as awful as people say
My son died by suicide – I’m trying to save others
King Charles ‘deeply touched’ by reaction to ‘good news’ about his cancer
Strictly favourite just dropped biggest hint yet she’s replacing Tess Daly and Claudia Winkleman
A text about a schoolfriend changed my entire approach to parenting
Hosting Christmas for the family nearly killed me